(Q52212480)

27 April 2018

title

Accrual strategies for phase I trials with delayed patient outcome. (English)

1 reference

27 April 2018

main subject

phase I clinical trial

0 references

1 reference

Thall PF

1

1 reference

27 April 2018

Lee JJ

series ordinal

2

1 reference

27 April 2018

Tseng CH

series ordinal

3

1 reference

27 April 2018

Estey EH

series ordinal

4

1 reference

27 April 2018

language of work or name

English

0 references

publication date

1 May 1999

1 reference

27 April 2018

published in

Statistics in Medicine

1 reference

27 April 2018

volume

18

1 reference

27 April 2018

issue

10

1 reference

27 April 2018

page(s)

1155-1169

1 reference

27 April 2018

Continual reassessment method: a practical design for phase 1 clinical trials in cancer.

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0258%2819990530%2918%3A10%3C1155%3A%3AAID-SIM114%3E3.0.CO%3B2-H

Simulation as a design tool for phase I/II clinical trials: an example from bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0258%2819990530%2918%3A10%3C1155%3A%3AAID-SIM114%3E3.0.CO%3B2-H

Methods for dose finding studies in cancer clinical trials: a review and results of a Monte Carlo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0258%2819990530%2918%3A10%3C1155%3A%3AAID-SIM114%3E3.0.CO%3B2-H

Continual reassessment method: a likelihood approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0258%2819990530%2918%3A10%3C1155%3A%3AAID-SIM114%3E3.0.CO%3B2-H

Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0258%2819990530%2918%3A10%3C1155%3A%3AAID-SIM114%3E3.0.CO%3B2-H

New statistical strategy for monitoring safety and efficacy in single-arm clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0258%2819990530%2918%3A10%3C1155%3A%3AAID-SIM114%3E3.0.CO%3B2-H

A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0258%2819990530%2918%3A10%3C1155%3A%3AAID-SIM114%3E3.0.CO%3B2-H

Some extensions and applications of a Bayesian strategy for monitoring multiple outcomes in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0258%2819990530%2918%3A10%3C1155%3A%3AAID-SIM114%3E3.0.CO%3B2-H

Continuously monitored stopping boundary methodologies: the issues of sensitivity, association and trial suspension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0258%2819990530%2918%3A10%3C1155%3A%3AAID-SIM114%3E3.0.CO%3B2-H

A comparison of two phase I trial designs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0258%2819990530%2918%3A10%3C1155%3A%3AAID-SIM114%3E3.0.CO%3B2-H

An extension of the continual reassessment methods using a preliminary up-and-down design in a dose finding study in cancer patients, in order to investigate a greater range of doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0258%2819990530%2918%3A10%3C1155%3A%3AAID-SIM114%3E3.0.CO%3B2-H

Some practical improvements in the continual reassessment method for phase I studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0258%2819990530%2918%3A10%3C1155%3A%3AAID-SIM114%3E3.0.CO%3B2-H

Design of phase I and II clinical trials in cancer: a statistician's view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0258%2819990530%2918%3A10%3C1155%3A%3AAID-SIM114%3E3.0.CO%3B2-H

Design and analysis of phase I clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0258%2819990530%2918%3A10%3C1155%3A%3AAID-SIM114%3E3.0.CO%3B2-H

10.1002/(SICI)1097-0258(19990530)18:10<1155::AID-SIM114>3.0.CO;2-H

21 January 2018

Identifiers

DOI

1 reference

27 April 2018

1 reference

27 April 2018